Genome Announc. 2016 Mar 31;4(2). pii: e00181-16. doi: 10.1128/genomeA.00181-16.

Draft Genome Sequences of Streptococcus pneumoniae with High-Level Resistance to Respiratory Fluoroquinolones.

Keness Y1, Bisharat N2.

Author information

Abstract

Streptococcus pneumoniaeis the leading cause of community-acquired pneumonia. Levofloxacin is a fluoroquinolone used for treatment of severe community-acquired pneumonia. Here, we describe the draft genome sequences ofS. pneumoniaewith emerging resistance to levofloxacin, resulting in failure of treatment of pneumococcal pneumonia.

Copyright © 2016 Keness and Bisharat.

PMID: 27034491 [PubMed] PMCID: PMC4816619